Largest study into treatment for chronic pelvic pain
Professor Andrew Horne, researcher at MRC Centre for Reproductive Health, is leading the largest study into treatment for chronic pelvic pain
His paper ‘Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial’ was published in The Lancet on 26 September, 2020:
This is the largest ever study into treatment for female chronic pelvic pain and Professor Horne and his team at MRC Centre for Reproductive Health have discovered that gabaprentin - a commonly prescribed drug for sufferers of chronic pelvic pain - has no more benefits than a placebo.
A press release by the University of Edinburgh press office has generated extensive national media coverage, including:
It has also appeared in 25 regional newspapers.